Literature DB >> 20350936

Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia.

Faranak Farzan1, Mera S Barr, Andrea J Levinson, Robert Chen, Willy Wong, Paul B Fitzgerald, Zafiris J Daskalakis.   

Abstract

Previous studies have shown that patients with schizophrenia and bipolar disorder have deficits in cortical inhibition. Through the combination of interleaved transcranial magnetic stimulation and electroencephalography, we have recently reported on methods in which cortical inhibition can be measured from the dorsolateral prefrontal cortex, a cortical region that is more closely associated with the pathophysiology of schizophrenia. Furthermore, it is possible to index cortical inhibition of specific oscillatory frequencies including the gamma band (30-50 Hz) whose modulation has been related to higher order cortical processing. In this study, we show that patients with schizophrenia have significant deficits of cortical inhibition of gamma oscillations in the dorsolateral prefrontal cortex compared to healthy subjects and patients with bipolar disorder, while no deficits are demonstrated in the motor cortex. These results suggest that the lack of inhibition of gamma oscillations in the dorsolateral prefrontal cortex may represent an important frontal neurophysiological deficit, which may be responsible for the spectrum of deficits commonly found in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20350936     DOI: 10.1093/brain/awq046

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  54 in total

Review 1.  Inhibition of the cortex using transcranial magnetic stimulation in psychiatric populations: current and future directions.

Authors:  Natasha Radhu; Lakshmi N Ravindran; Andrea J Levinson; Zafiris J Daskalakis
Journal:  J Psychiatry Neurosci       Date:  2012-11       Impact factor: 6.186

2.  Reduced natural oscillatory frequency of frontal thalamocortical circuits in schizophrenia.

Authors:  Fabio Ferrarelli; Simone Sarasso; Yelena Guller; Brady A Riedner; Michael J Peterson; Michele Bellesi; Marcello Massimini; Bradley R Postle; Giulio Tononi
Journal:  Arch Gen Psychiatry       Date:  2012-08

3.  Lasting modulation effects of rTMS on neural activity and connectivity as revealed by resting-state EEG.

Authors:  Lei Ding; Guofa Shou; Han Yuan; Diamond Urbano; Yoon-Hee Cha
Journal:  IEEE Trans Biomed Eng       Date:  2014-03-25       Impact factor: 4.538

4.  The EEG correlates of the TMS-induced EMG silent period in humans.

Authors:  Faranak Farzan; Mera S Barr; Sylco S Hoppenbrouwers; Paul B Fitzgerald; Robert Chen; Alvaro Pascual-Leone; Zafiris J Daskalakis
Journal:  Neuroimage       Date:  2013-06-22       Impact factor: 6.556

Review 5.  Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.

Authors:  Bernat Kocsis; Ritchie E Brown; Robert W McCarley; Mihaly Hajos
Journal:  CNS Neurosci Ther       Date:  2013-04-24       Impact factor: 5.243

Review 6.  Transcranial magnetic stimulation: a neuroscientific probe of cortical function in schizophrenia.

Authors:  Shawn M McClintock; Catarina Freitas; Lindsay Oberman; Sarah H Lisanby; Alvaro Pascual-Leone
Journal:  Biol Psychiatry       Date:  2011-05-14       Impact factor: 13.382

Review 7.  Measuring GABAergic inhibitory activity with TMS-EEG and its potential clinical application for chronic pain.

Authors:  Mera S Barr; Faranak Farzan; Karen D Davis; Paul B Fitzgerald; Zafiris J Daskalakis
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-29       Impact factor: 4.147

8.  Characterization of Glutamatergic and GABAA-Mediated Neurotransmission in Motor and Dorsolateral Prefrontal Cortex Using Paired-Pulse TMS-EEG.

Authors:  Robin F H Cash; Yoshihiro Noda; Reza Zomorrodi; Natasha Radhu; Faranak Farzan; Tarek K Rajji; Paul B Fitzgerald; Robert Chen; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  Neuropsychopharmacology       Date:  2016-07-27       Impact factor: 7.853

9.  Targeting Gamma-Related Pathophysiology in Autism Spectrum Disorder Using Transcranial Electrical Stimulation: Opportunities and Challenges.

Authors:  Fae B Kayarian; Ali Jannati; Alexander Rotenberg; Emiliano Santarnecchi
Journal:  Autism Res       Date:  2020-05-28       Impact factor: 5.216

10.  Altered prefrontal activity and connectivity predict different cognitive deficits in schizophrenia.

Authors:  Fabio Ferrarelli; Brady A Riedner; Michael J Peterson; Giulio Tononi
Journal:  Hum Brain Mapp       Date:  2015-08-19       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.